New Antineoplastic Agents View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1989

AUTHORS

D. Schmähl , M. R. Berger , B. K. Keppler , T. Klenner

ABSTRACT

New antineoplastic agents are being developed predominantly in industrial laboratories and only to a limited extent in university and other research institutes. The results of so-called screening assays, as conducted especially by the National Cancer Institute, have been disappointing in particular since the testing of many hundreds or thousands of substances did not yield any appreciable result. It therefore seems to be important to find a rational basis for research and not to use a shotgun method to detect new antineoplastic agents. More... »

PAGES

95-110

Book

TITLE

Cancer Therapy

ISBN

978-3-540-51034-5
978-3-642-74683-3

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-642-74683-3_11

DOI

http://dx.doi.org/10.1007/978-3-642-74683-3_11

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1048779838


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "familyName": "Schm\u00e4hl", 
        "givenName": "D.", 
        "id": "sg:person.0105462430.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0105462430.55"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Berger", 
        "givenName": "M. R.", 
        "id": "sg:person.01256203524.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256203524.22"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Keppler", 
        "givenName": "B. K.", 
        "id": "sg:person.0606573400.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606573400.82"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Klenner", 
        "givenName": "T.", 
        "id": "sg:person.01055432617.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055432617.13"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1989", 
    "datePublishedReg": "1989-01-01", 
    "description": "New antineoplastic agents are being developed predominantly in industrial laboratories and only to a limited extent in university and other research institutes. The results of so-called screening assays, as conducted especially by the National Cancer Institute, have been disappointing in particular since the testing of many hundreds or thousands of substances did not yield any appreciable result. It therefore seems to be important to find a rational basis for research and not to use a shotgun method to detect new antineoplastic agents.", 
    "editor": [
      {
        "familyName": "Bannasch", 
        "givenName": "Peter", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-642-74683-3_11", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-540-51034-5", 
        "978-3-642-74683-3"
      ], 
      "name": "Cancer Therapy", 
      "type": "Book"
    }, 
    "keywords": [
      "new antineoplastic agents", 
      "antineoplastic agents", 
      "National Cancer Institute", 
      "Cancer Institute", 
      "screening assays", 
      "rational basis", 
      "agents", 
      "thousands of substances", 
      "Institute", 
      "assays", 
      "limited extent", 
      "testing", 
      "substances", 
      "results", 
      "extent", 
      "laboratory", 
      "Research Institute", 
      "appreciable results", 
      "University", 
      "basis", 
      "research", 
      "method", 
      "hundreds", 
      "thousands", 
      "shotgun method", 
      "industrial laboratories"
    ], 
    "name": "New Antineoplastic Agents", 
    "pagination": "95-110", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1048779838"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-642-74683-3_11"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-642-74683-3_11", 
      "https://app.dimensions.ai/details/publication/pub.1048779838"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-12-01T06:47", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/chapter/chapter_136.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-642-74683-3_11"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-74683-3_11'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-74683-3_11'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-74683-3_11'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-74683-3_11'


 

This table displays all metadata directly associated to this object as RDF triples.

99 TRIPLES      22 PREDICATES      51 URIs      44 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-642-74683-3_11 schema:about anzsrc-for:11
2 anzsrc-for:1115
3 schema:author N9eaf6bb7c55840d690cbcdf815547d6e
4 schema:datePublished 1989
5 schema:datePublishedReg 1989-01-01
6 schema:description New antineoplastic agents are being developed predominantly in industrial laboratories and only to a limited extent in university and other research institutes. The results of so-called screening assays, as conducted especially by the National Cancer Institute, have been disappointing in particular since the testing of many hundreds or thousands of substances did not yield any appreciable result. It therefore seems to be important to find a rational basis for research and not to use a shotgun method to detect new antineoplastic agents.
7 schema:editor N5c3676197a9140439bb4592ff3beab5d
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf N5a9c6f84d01a4ad9a20cd55f8b10211e
11 schema:keywords Cancer Institute
12 Institute
13 National Cancer Institute
14 Research Institute
15 University
16 agents
17 antineoplastic agents
18 appreciable results
19 assays
20 basis
21 extent
22 hundreds
23 industrial laboratories
24 laboratory
25 limited extent
26 method
27 new antineoplastic agents
28 rational basis
29 research
30 results
31 screening assays
32 shotgun method
33 substances
34 testing
35 thousands
36 thousands of substances
37 schema:name New Antineoplastic Agents
38 schema:pagination 95-110
39 schema:productId N5c054be8275745809669919f7c93b42a
40 Nb9ffe96758e24da2a95ce7d40d57abe3
41 schema:publisher N6bb3fad7e922414f8fccc8c759038bdd
42 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048779838
43 https://doi.org/10.1007/978-3-642-74683-3_11
44 schema:sdDatePublished 2022-12-01T06:47
45 schema:sdLicense https://scigraph.springernature.com/explorer/license/
46 schema:sdPublisher Nfac6561b2d924200b7626cb66c9d8e68
47 schema:url https://doi.org/10.1007/978-3-642-74683-3_11
48 sgo:license sg:explorer/license/
49 sgo:sdDataset chapters
50 rdf:type schema:Chapter
51 N3033b2891475490fa57de51d39ff7ba4 rdf:first sg:person.01256203524.22
52 rdf:rest Nbbfa3656e9eb4088956a10fb62870244
53 N5a9c6f84d01a4ad9a20cd55f8b10211e schema:isbn 978-3-540-51034-5
54 978-3-642-74683-3
55 schema:name Cancer Therapy
56 rdf:type schema:Book
57 N5c054be8275745809669919f7c93b42a schema:name doi
58 schema:value 10.1007/978-3-642-74683-3_11
59 rdf:type schema:PropertyValue
60 N5c3676197a9140439bb4592ff3beab5d rdf:first N6b03add191de4b0a92cc2ee04b5beb12
61 rdf:rest rdf:nil
62 N6b03add191de4b0a92cc2ee04b5beb12 schema:familyName Bannasch
63 schema:givenName Peter
64 rdf:type schema:Person
65 N6bb3fad7e922414f8fccc8c759038bdd schema:name Springer Nature
66 rdf:type schema:Organisation
67 N9eaf6bb7c55840d690cbcdf815547d6e rdf:first sg:person.0105462430.55
68 rdf:rest N3033b2891475490fa57de51d39ff7ba4
69 Na04afcfd017748d49207392c51f0a279 rdf:first sg:person.01055432617.13
70 rdf:rest rdf:nil
71 Nb9ffe96758e24da2a95ce7d40d57abe3 schema:name dimensions_id
72 schema:value pub.1048779838
73 rdf:type schema:PropertyValue
74 Nbbfa3656e9eb4088956a10fb62870244 rdf:first sg:person.0606573400.82
75 rdf:rest Na04afcfd017748d49207392c51f0a279
76 Nfac6561b2d924200b7626cb66c9d8e68 schema:name Springer Nature - SN SciGraph project
77 rdf:type schema:Organization
78 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
79 schema:name Medical and Health Sciences
80 rdf:type schema:DefinedTerm
81 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
82 schema:name Pharmacology and Pharmaceutical Sciences
83 rdf:type schema:DefinedTerm
84 sg:person.0105462430.55 schema:familyName Schmähl
85 schema:givenName D.
86 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0105462430.55
87 rdf:type schema:Person
88 sg:person.01055432617.13 schema:familyName Klenner
89 schema:givenName T.
90 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055432617.13
91 rdf:type schema:Person
92 sg:person.01256203524.22 schema:familyName Berger
93 schema:givenName M. R.
94 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256203524.22
95 rdf:type schema:Person
96 sg:person.0606573400.82 schema:familyName Keppler
97 schema:givenName B. K.
98 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606573400.82
99 rdf:type schema:Person
 




Preview window. Press ESC to close (or click here)


...